2006³â 5¿ù 1ÀϺÎÅÍ ¿£ºê·¼Àû¿ë 2006-05-03 ¹®ÇõÁØ |
¿£ºê·¼ÀÇ º¸ÇèÀû¿ëÀÌ 2005³â 5¿ù 10ÀϺÎÅÍ ÀÌ·ïÁ³À¸³ª,
º¸ÇèÀû¿ë ±âÇÑÀÌ 9°³¿ù·Î µÇ¾î ÀÖ¾ú½À´Ï´Ù. 2006³â 5¿ù 1ÀϺÎÅÍ ÃÑ 24°³¿ù·Î ±âÇÑÀÌ ¿¬ÀåµË´Ï´Ù. ±×¸®°í, ¿£ºê·¼ÀÇ ¾à°¡µµ 10%ÀÎÇϸ¦ Çϱâ·Î °áÁ¤µÇ¾ú½À´Ï´Ù. ´Þ¶óÁø ³»¿ëÀº ´ÙÀ½°ú °°½À´Ï´Ù. 1) ÃÑ 9°³¿ù¿¡¼ 24°³¿ù·Î ¿¬ÀåµÇ¾ú½À´Ï´Ù. 2) ±âÇÑÀÇ »êÁ¤¿¡ ÀÖ¾î ±âÁ¸¿¡´Â ¿£ºê·¼ÀÇ Åõ¿©½ÃÀÛ°ú ÇÔ²² Áß°£¿¡ Áֻ縦 ÇÏÁö ¾Ê¾Æµµ Àϼö°¡ Æ÷ÇÔÀÌ µÇ¾úÀ¸³ª, À̹ø¿¡´Â ½ÇÁ¦ Áֻ緮À¸·Î º¯°æµÇ¾ú½À´Ï´Ù. (ÃÖ´ë 208¹ÙÀ̾˱îÁö ±Þ¿© ÀÎÁ¤µË´Ï´Ù.) °Á÷¼ºÃ´Ãß¿°ÀÇ ¿£ºê·¼(etanercept) º¸ÇèÀû¿ë ±âÁØ ---------------------------------------------- ¥². ÁßÁõÀÇ °Á÷¼ºÃ´Ãß¿° °¡) Åõ¿©´ë»ó : µÎ°¡Áö Á¾·ù ÀÌ»óÀÇ NSAIDs ȤÀº DMARDs ¾àÁ¦·Î 3°³¿ù ÀÌ»ó Ä¡·á¸¦ ÇÏ¿´À¸³ª Ä¡·áÈ¿°ú°¡ ¹ÌÈíÇϰųª, »ó±â ¾àÁ¦µéÀÇ ºÎÀÛ¿ë µîÀ¸·Î Ä¡·á¸¦ Áß´ÜÇÑ, ÁßÁõÀÇ È°µ¿¼º °Á÷¼º ôÃß¿° ȯÀÚ ¡Ø ÁßÁõÀÇ È°µ¿¼º °Á÷¼º ôÃß¿° : Modified New York criteria 1984(¾Æ·¡ ÂüÁ¶)¸¦ ±Ù°Å·Î ÇÏ¿©, ¹æ»ç¼±ÇÐÀû ±âÁØ (Radiologic criteria)°ú 2°³ ÀÌ»ó(aÇ×Àº ¹Ýµå½Ã Æ÷ÇÔ)ÀÇ ÀÓ»óÀû ±âÁØ(Clinical criteria)À» µ¿½Ã¿¡ ¸¸Á·Çϸç, Bath Ankylosing Spondilitis Disease Activity Index (BASDAI)°¡ Àû¾îµµ 4 ÀÌ»óÀÎ °æ¿ì 1. Radiologic criteria (¹æ»ç¼±ÇÐÀû ±âÁØ) ----Sacroilitis: Grade ¡Ã2 bilateral or Grade 3 or 4 unilateral. (õÀå°ñ¿° : ¾çÃø¼º Grade 2ÀÌ»ó, ÆíÃø¼º Grade 3 ȤÀº 4) 2. Clinical criteria (ÀÓ»óÀû ±âÁØ) a. Low back pain and stiffness for more than 3months, which improves with exercise but is not relieved by rest.(¿îµ¿½Ã È£ÀüµÇ³ª, ÈÞ½ÄÀ¸·Î´Â È£Àü µÇÁö ¾Ê´Â 3°³¿ù ÀÌ»óÀÇ low back pain°ú °Á÷) b. Limitation of motion of the lumbar spine in both the sagittal and frontal planes. (½Ã»ó¸é°ú ÀüµÎ¸é ¸ðµÎ¿¡¼ ¿äÃß°ñ ¿îµ¿ÀÇ Á¦ÇÑ) c. Limitation of chest expansion.(ÈäºÎÆØâÀÇ Á¦ÇÑ) ³ª) Åõ¿©±â°£ ¹× Æò°¡¹æ¹ý : Åõ¿© 3°³¿ù° Æò°¡¸¦ ÅëÇÏ¿© BASDAI°¡ 50% ¶Ç´Â 2(scale 0-10)ÀÌ»ó °¨¼ÒÇÑ °æ¿ì Ãß°¡ 6°³¿ùÀÇ Åõ¿©¸¦ ÀÎÁ¤ÇÔ. - ÀÌÈÄ¿¡´Â ¾àÁ¦ »ç¿ë 6°³¿ù¸¶´Ù Æò°¡¸¦ ÇÏ¿© ù 3°³¿ù°ÀÇ Æò°¡ °á°ú°¡ À¯ÁöµÇ¸é Ãß°¡ Åõ¿©¸¦ ÀÎÁ¤ÇÔ (ÃÖ´ë 24°³¿ù) ¡Ø ±Þ¿©ÀÎÁ¤ ±â°£¿¡ ´ëÇÑ ¼³¸í µ¿ ¾àÁ¦´Â ù 3°³¿ùÀº ¿øÄ¢ÀûÀ¸·Î Áö¼Ó Åõ¿©, ÀÌÈÄ Ãß°¡ ±Þ¿© ÀÎÁ¤±â°£(21°³¿ù)Àº ½ÇÁ¦ Åõ¿©±â°£ ÇÕ»ê. Áï, ÀÇÇÐÀû Áß´Ü»çÀ¯ µîÀ¸·Î ÀÏÁ¤±â°£ ÈÞ¾àÇÑ °æ¿ì¿¡´Â Åõ¿© Áß´Ü ±â°£À» Á¦¿ÜÇÏ°í ÇÕ»ê ´Ù) Åõ¿©±â°£ »êÁ¤¹æ¹ý ÀÌ ¾àÁ¦´Â 1ÁÖ¿¡ 2¹ÙÀ̾Ë(50mg)ÀÌ »ó¿ë·®À̸ç, °Á÷¼ºÃ´Ãß¿°ÀÇ °æ¿ì ÈÞ¾à ±â°£ÀÌ ÀÎÁ¤µÇ¹Ç·Î ó¹æ·® 8¹ÙÀ̾ËÀ» 4ÁÖ·Î °è»êÇÏ¿© »ç¿ë±â°£À» »êÁ¤ÇÔ. Áï, 24°³¿ùÀÇ °æ¿ì ÃÑ 104ÁÖ¿¡ ÇØ´çÇϹǷΠÃÖ´ë 208¹ÙÀ̾˱îÁö ±Þ¿© ÀÎÁ¤µÊ |
|
|||
|
|
|
HOME > °Ô½ÃÆÇ > ÀÚÀ¯°Ô½ÃÆÇ